1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid

Catalog No. :
ACBGRT176
CAS No. :
856256-63-8
Molecular Formula :
C9H12N2O2
Molecular Weight :
180.21

IUPAC Name:1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxylic acid

1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$64.00Login to see priceIn stockInquiry
1g95%$126.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid
IUPAC Name1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxylic acid
Molecular FormulaC9H12N2O2
Molecular Weight180.21
SMILESO=C(C1=NNC2=C1CCCCC2)O
InChI KeyNFNLJMOKEMQHAB-UHFFFAOYSA-N
Synonym1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxylic acid;1H,4H,5H,6H,7H,8H-Cyclohepta[c]pyrazole-3-carboxylic acid;1,4,5,6,7,8-hexahydrocyclohepta[d]pyrazole-3-carboxylic acid;3-Cycloheptapyrazolecarboxylic acid, 1,4,5,6,7,8-hexahydro-;1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid - [H94491]
CAS No.856256-63-8
PubChem CID655343

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBGRT176 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBGRT176 route product structure diagram
    ACBGRT176856256-63-8 In Stock
Inquiry

2. ACBGRT176 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBGRT176 route product structure diagram
    ACBGRT176856256-63-8 In Stock
Inquiry

Comments (0)